Cargando…

CD38: From Positive to Negative Expression after Daratumumab Treatment

CD38 is a glycoprotein expressed at a low level in myeloid and lymphoid tissues. However, it is highly and homogeneously expressed in plasma cells (PC) in multiple myeloma. Daratumumab is a human CD38-specific IgG1 antibody available for the treatment of multiple myeloma in Colombia. It has been aut...

Descripción completa

Detalles Bibliográficos
Autores principales:	Patiño-Escobar, Bonell, Ramos, Roberto, Linares, Maximo, Mejía, Angie, Alcalá, Sebastián
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Cureus 2020
Materias:	Internal Medicine
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7213648/ https://www.ncbi.nlm.nih.gov/pubmed/32399359 http://dx.doi.org/10.7759/cureus.7627

Ejemplares similares

Myelomastocytic Blast Cell Crisis in Resistant Tyrosine Kinase Inhibitor Chronic Myelogenous Leukemia: Case Report and Review of Literature
por: Martinez-Cordero, Humberto, et al.
Publicado: (2019)

Role of Daratumumab in Combination With Standard Therapies in Patients With Relapsed and Refractory Multiple Myeloma
por: Bapatla, Anusha, et al.
Publicado: (2021)

Mechanisms of Resistance to Anti-CD38 Daratumumab in Multiple Myeloma
por: Saltarella, Ilaria, et al.
Publicado: (2020)

Efficacy of Daratumumab-Based Regimens Compared to Standard of Care in Transplant-Eligible Multiple Myeloma: A Meta-Analysis
por: Menon, Trishala, et al.
Publicado: (2021)

DNA methyltransferase inhibitors upregulate CD38 protein expression and enhance daratumumab efficacy in multiple myeloma
por: Choudhry, Priya, et al.
Publicado: (2019)

Daratumumab: a first-in-class CD38 monoclonal antibody for the treatment of multiple myeloma
por: Sanchez, Larysa, et al.
Publicado: (2016)

Daratumumab induces mechanisms of immune activation through CD38+ NK cell targeting
por: Viola, Domenico, et al.
Publicado: (2020)

CD38-targeted therapy with daratumumab reduces autoantibody levels in multiple myeloma patients
por: Frerichs, Kristine A., et al.
Publicado: (2019)

CD38‐Targeted Theranostics of Lymphoma with (89)Zr/(177)Lu‐Labeled Daratumumab
por: Kang, Lei, et al.
Publicado: (2021)

B-cell targeting with anti-CD38 daratumumab: implications for differentiation and memory responses
por: Verhoeven, Dorit, et al.
Publicado: (2023)

CD-20 Negative Plasmablastic Lymphoma Lurking in the Shadow of a Leiomyoma – Diagnosis and Management
por: Bindra, Bikramjit S, et al.
Publicado: (2019)

The role of daratumumab in relapsed/refractory CD38 positive acute leukemias—case report on three cases with a literature review
por: Prejzner, Witold, et al.
Publicado: (2023)

CD38-specific nanobodies allow in vivo imaging of multiple myeloma under daratumumab therapy
por: Pape, Luca Julius, et al.
Publicado: (2022)

Balancing the CD38 Expression on Effector and Target Cells in Daratumumab-Mediated NK Cell ADCC against Multiple Myeloma
por: Lejeune, Margaux, et al.
Publicado: (2021)

CD38 antibody re-treatment in daratumumab-refractory multiple myeloma after time on other therapies
por: Perez de Acha, Olivia, et al.
Publicado: (2023)

Proximal Myopathy With Hypercalcemic Crisis and Papillary Thyroid Carcinoma in a 38-Year-Old Female
por: Huq, Muhammad Rezeul, et al.
Publicado: (2021)

Detection of granzyme B in CD3-positive cells infiltrated in lesional skin of a dog with erythema multiforme associated with zonisamide
por: TANAKA, Nana, et al.
Publicado: (2021)

Targeting CD38 with Daratumumab Plus Chemotherapy for Patients with Advanced-Stage Plasmablastoid Large B-Cell Lymphoma
por: Ryu, Yun Kyoung, et al.
Publicado: (2022)

Upregulation of CD38 expression on multiple myeloma cells by novel HDAC6 inhibitors is a class effect and augments the efficacy of daratumumab
por: García-Guerrero, Estefanía, et al.
Publicado: (2020)

CD4(+) T Cell Cytokine Gene and Protein Expression in Duodenal Mucosa of Dogs with Inflammatory Bowel Disease
por: OHTA, Hiroshi, et al.
Publicado: (2013)

A Case Report of Accelerated Pulmonary Silicosis: Hazardous Exposure in Underrepresented Community Members
por: Patino, Sara, et al.
Publicado: (2022)

Daratumumab in the treatment of C3 glomerulopathy with monoclonal gammopathy: a case report and literature review
por: Esposito, Pasquale, et al.
Publicado: (2023)

Subarachnoid Neurocysticercosis Presenting as a New-Onset Seizure in an Immigrant From Guatemala
por: Clark, Shane, et al.
Publicado: (2021)

Gram-Negative Pyomyositis in an Immunocompetent Patient
por: Knees, Michelle, et al.
Publicado: (2018)

The therapeutic human CD38 antibody daratumumab improves the anti-myeloma effect of newly emerging multi-drug therapies
por: van der Veer, M S, et al.
Publicado: (2011)

Daratumumab and Nanobody-Based Heavy Chain Antibodies Inhibit the ADPR Cyclase but not the NAD(+) Hydrolase Activity of CD38-Expressing Multiple Myeloma Cells
por: Baum, Natalie, et al.
Publicado: (2020)

Fungal Peritonitis Associated With Peritoneal Dialysis Due to Non-Albicans Candida: A Case Series
por: Juarez Villa, Daniel, et al.
Publicado: (2022)

Suspicion Is Key: Diagnosing Elusive Cytoplasmic Antineutrophil Cytoplasmic Antibody (c-ANCA)-Positive Vasculitis
por: Crowe, Timothy P, et al.
Publicado: (2022)

A rapid multiple immunofluorescence method for the simultaneous detection of CD20 and CD3 in canine and feline cytological samples
por: MATSUMOTO, Fumi, et al.
Publicado: (2021)

Extracellular Vesicles Isolated from Plasma of Multiple Myeloma Patients Treated with Daratumumab Express CD38, PD-L1, and the Complement Inhibitory Proteins CD55 and CD59
por: Brennan, Kieran, et al.
Publicado: (2022)

Serial Changes of CD4+CD25+FoxP3+ Regulatory T Cell in Canine Model of Sepsis Induced by Endotoxin
por: YU, Dohyeon, et al.
Publicado: (2014)

Non-surgical Pneumoperitoneum in the Setting of Gram-negative Sepsis
por: Sambursky, Jacob A, et al.
Publicado: (2018)

Culture-Negative Fibrinous Peritonitis in a Postpartum Female
por: Dhaliwal, Anand, et al.
Publicado: (2023)

Clinical, Biochemical, and Radiological Presentation of RT-PCR-Positive vs RT-PCR-Negative SARS-CoV-2 Pneumonia Requiring ICU Care: An Observational, Cross-Sectional, Single-Center Study in Kalaburagi, Kalyana Karnataka
por: Waddankeri, Swaraj, et al.
Publicado: (2022)

Use of Dexmedetomidine in Early Prone Positioning Combined With High-Flow Nasal Cannula and Non-Invasive Positive Pressure Ventilation in a COVID-19 Positive Patient
por: Cruz Salcedo, Elis M, et al.
Publicado: (2020)

Publisher Correction: Upregulation of CD38 expression on multiple myeloma cells by novel HDAC6 inhibitors is a class effect and augments the efficacy of daratumumab
por: García-Guerrero, Estefanía, et al.
Publicado: (2021)

Emergency Medicine Challenges in Ecuador
por: Patiño, Andrés M., et al.
Publicado: (2020)

Anti‐CD38 monoclonal antibody interference with blood compatibility testing: Differentiating isatuximab and daratumumab via functional epitope mapping
por: Chami, Btissam, et al.
Publicado: (2022)

Progressive Multifocal Leukoencephalopathy Associated With Idiopathic CD8+ Lymphocytopenia
por: Lopes, Marta, et al.
Publicado: (2022)

A Case of Novel Corona Virus With Three Negative Nasopharyngeal Swabbings
por: She, Tianyu, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_vo7vm0m0igethitfmlvcnfe35q